Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke

ClinicalTrials.gov ID: NCT00924638

Public ClinicalTrials.gov record NCT00924638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CRYptogenic STroke And underLying AF Trial

Study identification

NCT ID
NCT00924638
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Industry
Enrollment
447 participants

Conditions and interventions

Interventions

  • Reveal® XT Insertable Cardiac Monitor Device

Device

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2009
Primary completion
Apr 30, 2013
Completion
Apr 30, 2013
Last update posted
Jul 27, 2014

2009 – 2013

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
El Camino Hospital Mountain View California
South Denver Cardiology / Swedish Medical Center Denver Colorado
Northwestern Memorial Hospital Chicago Illinois
Iowa Heart / Ruan Neurology Des Moines Iowa
Louisville Cardiology Louisville Kentucky
Cardiology Associates Research, LLC Tupelo Mississippi
Mid America Heart Institute / St. Lukes Hospital Kansas City Missouri
Washington University Medical School St Louis Missouri
Hackensack University Medical Center Hackensack New Jersey
Forsyth Medical Center Winston-Salem North Carolina
Ohio Health Research Columbus Ohio
Sacred Heart Medical Center Eugene Oregon
Central Bucks Specialists / Doylestown Hospital Doylestown Pennsylvania
Thomas Jefferson University Philadelphia Pennsylvania
Lankenau Wynnewood Pennsylvania
Greenville Hospital System Cardiology/Cardiovascular Research Greenville South Carolina
St. Thomas Research Institute Nashville Tennessee
Baylor Research Institute Dallas Texas
University of Texas - Southwestern Medical Center Dallas Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00924638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00924638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →